- Home
- ILAG vs BMRA Comparison
ILAG vs BMRA Comparison
Compare ILAG & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILAG
- BMRA
- Stock Information
- Founded
- ILAG 1981
- BMRA 1971
- Country
- ILAG Hong Kong
- BMRA United States
- Employees
- ILAG N/A
- BMRA N/A
- Industry
- ILAG Office Equipment/Supplies/Services
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ILAG Consumer Discretionary
- BMRA Health Care
- Exchange
- ILAG Nasdaq
- BMRA Nasdaq
- Market Cap
- ILAG 18.4M
- BMRA 7.4M
- IPO Year
- ILAG 2022
- BMRA N/A
- Fundamental
- Price
- ILAG $0.98
- BMRA $0.32
- Analyst Decision
- ILAG
- BMRA
- Analyst Count
- ILAG 0
- BMRA 0
- Target Price
- ILAG N/A
- BMRA N/A
- AVG Volume (30 Days)
- ILAG 47.1K
- BMRA 68.2K
- Earning Date
- ILAG 11-29-2024
- BMRA 10-15-2024
- Dividend Yield
- ILAG N/A
- BMRA N/A
- EPS Growth
- ILAG N/A
- BMRA N/A
- EPS
- ILAG N/A
- BMRA N/A
- Revenue
- ILAG $6,443,357.00
- BMRA $5,509,000.00
- Revenue This Year
- ILAG N/A
- BMRA N/A
- Revenue Next Year
- ILAG N/A
- BMRA N/A
- P/E Ratio
- ILAG N/A
- BMRA N/A
- Revenue Growth
- ILAG N/A
- BMRA 1.74
- 52 Week Low
- ILAG $0.33
- BMRA $0.24
- 52 Week High
- ILAG $1.35
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- ILAG 44.56
- BMRA 47.45
- Support Level
- ILAG $0.97
- BMRA $0.28
- Resistance Level
- ILAG $1.06
- BMRA $0.35
- Average True Range (ATR)
- ILAG 0.06
- BMRA 0.03
- MACD
- ILAG -0.01
- BMRA 0.00
- Stochastic Oscillator
- ILAG 16.32
- BMRA 38.50
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.